A new prognostic score can predict survival after hepatocellular carcinoma treatment in a cohort of 1302 Egyptian hepatocellular carcinoma patients

European Journal of Gastroenterology & Hepatology
Ashraf Omar AbdelazizMohamed M Nabil

Abstract

Survival of hepatocellular carcinoma (HCC) differs between regions and countries according to the different underlying factors and the degree of standard of care that enables early diagnosis and management. Our aim was to identify the most potent predictive factors of survival in Egyptian HCC patients receiving curative or palliative treatments. This retrospective study included 1302 HCC patients attending the HCC multidisciplinary clinic, Cairo University, between February 2009 and December 2016. Clinical, laboratory, tumor characteristics, and treatment data were collected. Prognostic scores for each of the treatment categories, curative or palliative, were developed using routine laboratory tests. Patients were predominantly men, mean age 57.79±7.56 years. All cases developed HCC in addition to cirrhosis, mainly hepatitis C virus-related (88.2%). Most of the patients were Child-Pugh A (56.8%) or B (34.4%) and had single lesions. Transarterial chemoembolization was the most common line of treatment (42.08%). The overall median survival was 18.3 months from the date of diagnosis. Cigarette smoking, Child-Pugh score, performance status, number and size of the focal lesion, α-fetoprotein, and application of a specific treatment,...Continue Reading

References

Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M LlovetJ Bruix
Dec 17, 2004·Journal of the National Cancer Institute·Sun Ha JeeJonathan M Samet
Oct 13, 2006·Langenbeck's Archives of Surgery·Stephen S Hecht
Aug 6, 2008·Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community·Andreas D FlourisPanagiota Klentrou
Jan 14, 2009·World Journal of Gastroenterology : WJG·Diego Garcia-CompeanHector Maldonado-Garza
Jan 15, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Puneeta Tandon, Guadalupe Garcia-Tsao
Feb 3, 2011·Hepatology International·Amr S SolimanKadry Ismail
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Mar 1, 2012·International Journal of Cancer. Journal International Du Cancer·Wei-Liang ShihMing-Whei Yu
Sep 13, 2012·Experimental and Therapeutic Medicine·Abby B SiegelAlfred I Neugut
Jan 1, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Bachok Norsa'adah, Che Ghazali Che Nurhazalini-Zayani
Jan 16, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chien-Hsieh ChiangKuo-Chin Huang
Jun 18, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Ashraf Omar AbdelazizMohamed Mahmoud Nabeel
Jan 17, 2015·Scandinavian Journal of Gastroenterology·Ashraf Omar AbdelazizAhmed Hosni Abdelmaksoud
Mar 11, 2015·Journal of Clinical and Experimental Hepatology·Vivek A SaraswatSachin Shetty
Aug 16, 2015·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Elena RaffettiFrancesco Donato
Sep 6, 2015·Journal of Hepatology·Uttara SaranJean-François Dufour
Apr 14, 2017·The Lancet. Gastroenterology & Hepatology·Ju Dong YangUNKNOWN Africa Network for Gastrointestinal and Liver Diseases
May 4, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Philippe KollyJean-François Dufour

❮ Previous
Next ❯

Citations

Sep 25, 2020·International Journal of Pharmaceutics·Peipei MaLina Du

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.